An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer
about
Pharmacogenomic discovery using cell-based modelsDiscovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxPredictive and prognostic molecular markers for cancer medicineA 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions.Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cellsMicro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.Protein-protein interaction reveals synergistic discrimination of cancer phenotypeMicromarkers: miRNAs in cancer diagnosis and prognosis.Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells.MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.Is Chemoendocrine Treatment without Alternative?The use of genomic information to optimize cancer chemotherapyMicroRNA-mediated drug resistance in breast cancer.Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.An overview of microRNAsMicroRNAs in body fluids--the mix of hormones and biomarkersAn immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer.Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistanceComputational challenges in miRNA target predictions: to be or not to be a true target?Genomic advances and their impact on clinical trial designThe emerging role of microRNAs in cardiac remodeling and heart failure.MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.Key signalling nodes in mammary gland development and cancer: Myc.Genomic predictors of outcome and treatment response in breast cancer.miRNAs modulate the drug response of tumor cells.Oncoviruses and Pathogenic MicroRNAs in Humans.Clinical implications of chemotherapy-induced tumor gene expression in human breast cancers.Molecular basis for therapy resistance.MicroRNA and drug resistance.Emerging biomarkers in breast cancer care.microRNA regulation of cell viability and drug sensitivity in lung cancer.Maspin: molecular mechanisms and therapeutic implications.microRNA expression is able to predict response to chemoradiotherapy in rectal cancer.Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon.miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expressionMicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
P2860
Q28392982-D0F4FEEA-3F3E-49FC-9F55-58D33C4385C9Q28477021-DEEF6E0B-BA94-4178-A98B-4C09F94CD841Q28743108-7EC2F519-DCC7-414D-9D66-2CEF85AB2F9DQ33410103-A9F8237E-CB77-4954-9013-25A1E1010D57Q33565717-1AE1145B-7AF5-41D2-94A9-664351D6914FQ33585105-589B40D0-A5B4-4819-8BE0-01681B036981Q33813736-B327C341-F3E3-44E9-A185-DC81CA23F6BAQ33834478-6950E3CC-B862-499C-B085-8779F867A50BQ34108602-5E64E172-418E-469E-A62C-CFFD41FF86E7Q34145858-9B7ADD7B-FD02-44CB-AEB9-70776530C024Q34154782-8D6FCF0E-6545-4EC7-8F69-65209E8CC5C5Q34284263-7A111834-224D-4040-B1B3-5BC5C1F44A8EQ34791981-0AAC1359-D5A5-40CD-A465-D5B0EB44D3CEQ35165126-DC2A264E-B132-416C-8D57-32FA7F6D2324Q35583987-73B95B8B-752A-472B-94AF-3DE07C0D90FEQ35803441-4F505DE6-AD7E-4490-A61D-D986B20D924BQ35858483-66058607-6F36-4969-BFA7-4F6843B5DE66Q36176435-2383BCF0-BDE6-4B98-84CD-9CE521BA6F44Q36610246-32B8AAF9-07FF-4D5D-8F38-8E71FB2DE412Q37038698-CE9B79E8-AE43-48E4-B3FE-86B60485DC1BQ37097112-787098E5-3B54-4722-8C17-D10C4FF0FC5EQ37235215-1436EB3F-D0ED-4F68-8B73-FDF278FF0256Q37279699-5CCF76EE-E594-4015-B36E-B403ADD293EFQ37319218-CE07A6C9-DFD3-4D36-8874-15625E634FF1Q37383035-E3A80ECF-19C1-479A-A63A-33BECE0862F4Q37467223-56C4DB80-2944-4A15-9A76-80EC3D303D15Q37523889-5C54AB56-DCF2-4135-86CE-00A34B43AF5CQ37608111-54F83BD2-C762-477D-813E-5FFA2C5B6E26Q37634314-374EFF88-882D-4D33-A532-E852CC40D5A7Q37693959-1D89502C-6AFF-40D7-87AB-786E3627AB50Q37751530-F3E855EB-10D0-4F9C-96BD-8120F4D76E66Q37751868-E885C9DE-C491-429B-9A32-B429C4D42BE7Q37779305-C2D22E36-2C58-4A9B-8C36-F172700569FBQ38021509-1221780E-67A7-4898-A573-9389EADEB1E7Q38023237-271BE0B0-8F4B-436C-AC26-C2516155F38EQ38291943-1AD5647B-F8D0-4358-8164-280D5E6F37EFQ38348743-1205F4F9-F383-4FC3-808D-1E0186F24BF8Q38807275-98047CC6-D535-4297-A211-0F10962465B2Q38895915-AF277E9A-DBFD-4999-9035-2DEDA6E7E959Q39057246-30EBF4B1-299B-4105-A4C2-6B79EEF41269
P2860
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
An integrated approach to the ...... in patients with breast cancer
@ast
An integrated approach to the ...... in patients with breast cancer
@en
An integrated approach to the ...... in patients with breast cancer
@en-gb
An integrated approach to the ...... in patients with breast cancer
@nl
type
label
An integrated approach to the ...... in patients with breast cancer
@ast
An integrated approach to the ...... in patients with breast cancer
@en
An integrated approach to the ...... in patients with breast cancer
@en-gb
An integrated approach to the ...... in patients with breast cancer
@nl
altLabel
An Integrated Approach to the ...... in Patients with Breast Cancer
@en
prefLabel
An integrated approach to the ...... in patients with breast cancer
@ast
An integrated approach to the ...... in patients with breast cancer
@en
An integrated approach to the ...... in patients with breast cancer
@en-gb
An integrated approach to the ...... in patients with breast cancer
@nl
P2093
P2860
P921
P1433
P1476
An integrated approach to the ...... in patients with breast cancer
@en
P2093
Anil Potti
Ariel Anguiano
Carey K Anders
Chaitanya R Acharya
Holly K Dressman
John Olson
Joseph R Nevins
Katherine S Garman
Kelli S Walters
Kelly H Salter
P2860
P356
10.1371/JOURNAL.PONE.0001908
P407
P577
2008-01-01T00:00:00Z